pharmaceutical industry is an established sector in the United Kingdom
The pharmaceutical industry is an established sector in the United Kingdom that is driven by innovation as well as a desire to improve people’s health and save lives. New York Times reported that approximately 20% of the best selling drugs in the world are manufactured in the UK. Few giants dominate the UK pharmaceutical industry. According to Conor Stewart report published in January 2019, the giants include Pfizer which had a market share of 8.2% in 2018, followed by Novartis with a 6% market share, GlaxoSmithKline with 5.3% market share, Marck and Co. with 5.3% market share and Bayer with 4.6 market share (Stewart, 2019). Other companies with a significant market share, which was above 3%, include Roche, AbbVie, Johnson and Johnson, Sanofi, Gilead Sciences and AstraZena. These companies have a competitive market share and need to make great corporate strategies to retain or gain their market share. This report is an in-depth strategic analysis of GlaxoSmithKline, and it includes an analysis of GlaxoSmithKline external environment to show the opportunities in the industry, threats, and industry attractiveness. The reports also include GlaxoSmithKline’s internal environment analysis to show the company’s resources and key competencies that may give it a competitive advantage in the industry. Lastly, the GlaxoSmithKline’s recent strategy of merging with Pfizer is evaluated to show the sustainability, feasibility, and, acceptability of this strategy.